TRDA
Entrada Therapeutics, Inc. · Healthcare
President and CEO Dipal Doshi sold $36K of Entrada Therapeutics, Inc.
Sold$36,196
$15.02Price
2,410Shares
−1%Stake
What TRDA did after the filing
- The stock from Tue, Jan 10 close, $14.89
- −22.5%
- S&P 500, same days
- +2.6%
Measured over 30 trading days, to the Feb 23 close.
Traded Mon, Jan 9. Filed Tue, Jan 10, 11:40 AM ET, during the session. Returns use the Jan 10 close and the Feb 23 close. Not investment advice.